Veeva Systems Inc
General ticker "VEEV" information:
- Sector: Health Care
- Industry: Health Care Technology
- Capitalization: $37.3B
Veeva Systems Inc follows the US Stock Market performance with the rate: 31.9%.
Estimated limits based on current volatility of 1.7%: low 216.79$, high 224.17$
Factors to consider:
- North America accounted for 58.2% of revenue in the fiscal year ended 2023-01-31
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-01-31 to 2026-01-30
- 2024-01-31 to 2025-01-30 estimated range: [191.50$, 276.48$]
- 2025-01-30 to 2026-01-30 estimated range: [208.46$, 299.72$]
Financial Metrics affecting the VEEV estimates:
- Positive: Non-GAAP EPS, $ of 4.84 > 2.29
- Negative: Industry earnings per price (median), % of -6.16 <= 1.31
- Negative: Investing cash flow per share, $ of -6.70 <= -3.48
- Positive: Return on assets ratio (scaled to [-100,100]) of 8.17 > 7.10
- Positive: 9.05 < Operating profit margin, % of 18.16
- Positive: Inventory ratio change, % of -2.01 <= -1.03
- Negative: Industry operating cash flow per share per price (median), % of -3.94 <= 3.85
Short-term VEEV quotes
Long-term VEEV plot with estimates
Financial data
| YTD | 2022-01-31 | 2023-01-31 | 2024-01-31 |
|---|---|---|---|
| Operating Revenue | $1,850.78MM | $2,155.06MM | $2,363.67MM |
| Operating Expenses | $1,345.28MM | $1,695.97MM | $1,934.34MM |
| Operating Income | $505.50MM | $459.09MM | $429.33MM |
| Non-Operating Income | $6.82MM | $50.01MM | $158.69MM |
| Interest Expense | $14.73MM | $0.00MM | $0.00MM |
| R&D Expense | $382.04MM | $520.28MM | $629.03MM |
| Income(Loss) | $512.31MM | $509.10MM | $588.02MM |
| Taxes | $84.92MM | $21.39MM | $62.32MM |
| Profit(Loss) | $427.39MM | $487.71MM | $525.71MM |
| Stockholders Equity | $2,911.64MM | $3,716.25MM | $4,644.82MM |
| Inventory | $0.00MM | $0.00MM | $0.00MM |
| Assets | $3,816.47MM | $4,804.30MM | $5,910.92MM |
| Operating Cash Flow | $764.46MM | $780.47MM | $911.34MM |
| Capital expenditure | $2.49MM | $2.49MM | $26.20MM |
| Investing Cash Flow | $-346.15MM | $-1,007.68MM | $-1,076.35MM |
| Financing Cash Flow | $-4.14MM | $-19.38MM | $-16.19MM |
| Earnings Per Share* | $2.79 | $3.14 | $3.27 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.